Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72488399 | 7248839 | 9 | F | 2013 | 20160804 | 20100119 | 20160812 | EXP | PHHY2009CA56003 | NOVARTIS | 73.44 | YR | F | Y | 0.00000 | 20160812 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72488399 | 7248839 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | Y | 21008 | 30 | MG | /month | ||||||
| 72488399 | 7248839 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | Y | 21008 | 20 | MG | /month | ||||||
| 72488399 | 7248839 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY FOUR WEEKS) | Y | 21008 | 30 | MG | /month | ||||||
| 72488399 | 7248839 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY FOUR WEEKS) | Y | 21008 | 20 | MG | /month | ||||||
| 72488399 | 7248839 | 5 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 72488399 | 7248839 | 6 | C | GLYBURIDE. | GLYBURIDE | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 72488399 | 7248839 | 7 | C | OXYCONTIN PRN | 2 | Unknown | UNK, PRN | U | 0 | ||||||||||
| 72488399 | 7248839 | 8 | C | ACCUPRIL | QUINAPRIL HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 72488399 | 7248839 | 1 | Neuroendocrine tumour |
| 72488399 | 7248839 | 5 | Blood glucose abnormal |
| 72488399 | 7248839 | 6 | Blood glucose abnormal |
| 72488399 | 7248839 | 7 | Product used for unknown indication |
| 72488399 | 7248839 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 72488399 | 7248839 | OT |
| 72488399 | 7248839 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 72488399 | 7248839 | Abdominal distension | |
| 72488399 | 7248839 | Abdominal pain upper | |
| 72488399 | 7248839 | Blood glucose increased | |
| 72488399 | 7248839 | Blood potassium decreased | |
| 72488399 | 7248839 | Blood pressure increased | |
| 72488399 | 7248839 | Bone disorder | |
| 72488399 | 7248839 | Burning sensation | |
| 72488399 | 7248839 | Chromaturia | |
| 72488399 | 7248839 | Decreased appetite | |
| 72488399 | 7248839 | Diabetes mellitus | |
| 72488399 | 7248839 | Diabetic neuropathy | |
| 72488399 | 7248839 | Dyspnoea | |
| 72488399 | 7248839 | Ear discomfort | |
| 72488399 | 7248839 | Erythema | |
| 72488399 | 7248839 | Feeling abnormal | |
| 72488399 | 7248839 | Flushing | |
| 72488399 | 7248839 | Headache | |
| 72488399 | 7248839 | Hyperhidrosis | |
| 72488399 | 7248839 | Hypoaesthesia | |
| 72488399 | 7248839 | Injection site pain | |
| 72488399 | 7248839 | Malignant neoplasm progression | |
| 72488399 | 7248839 | Nausea | |
| 72488399 | 7248839 | Neoplasm progression | |
| 72488399 | 7248839 | Nervousness | |
| 72488399 | 7248839 | Oedema peripheral | |
| 72488399 | 7248839 | Pain | |
| 72488399 | 7248839 | Pain in extremity | |
| 72488399 | 7248839 | Paraesthesia | |
| 72488399 | 7248839 | Peripheral swelling | |
| 72488399 | 7248839 | Pruritus | |
| 72488399 | 7248839 | Rash pruritic | |
| 72488399 | 7248839 | Shock | |
| 72488399 | 7248839 | Sinusitis | |
| 72488399 | 7248839 | Skin discolouration | |
| 72488399 | 7248839 | Swelling | |
| 72488399 | 7248839 | Therapeutic response decreased | |
| 72488399 | 7248839 | Tinnitus | |
| 72488399 | 7248839 | Urinary tract infection | |
| 72488399 | 7248839 | Urine abnormality |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 72488399 | 7248839 | 1 | 20091211 | 20110303 | 0 | |
| 72488399 | 7248839 | 2 | 20110427 | 20120328 | 0 | |
| 72488399 | 7248839 | 3 | 20120715 | 20130313 | 0 | |
| 72488399 | 7248839 | 4 | 20130907 | 0 |